About Massive Bio

Every cancer patient deserves access to treatment options. Massive Bio is an AI-powered precision medicine platform transforming how cancer patients discover and access clinical trials by eliminating the barriers of geography, financial constraints, and information asymmetry that have historically limited enrollment. Founded in 2015 and headquartered in the US, as a recognized leader in health‑tech innovation Massive Bio is scaling its impact globally by powering operations across multiple countries. Through our proprietary AI platform, we connect individuals to clinical trials worldwide and partner with leading pharmaceutical companies, contract research organizations (CROs), and healthcare systems to accelerate drug development and expand equitable access to cutting‑edge therapies. Through our strong mission, we bring innovative cancer treatment options to a rapidly growing and diverse population of patients, while empowering clinicians and healthc...